During the past decade, CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" #1 collaborator was "PPD" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" are "Multiple Sclerosis, Primary Progressive" (1 trials), "Muscular Atrophy, Spinal" (1 trials), "Relapsing-Remitting Multiple Sclerosis" (1 trials) and "Spinal Muscular Atrophy" (1 trials). Many other conditions were trialed in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" in a lesser frequency.

Most popular intervention types in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Fenebrutinib" (1 trials), "Fingolimod" (1 trials), "Fingolimod Placebo" (1 trials) and "Ocrelizumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHRU de Montpellier, Hopital Gui de Chauliac; Service de Neuropediatrie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".